Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonas Nilsson

Showing results (41-50 of 146) with videos related to

Pageof 15
Sort By:
Radiation Protection Dosimetry|February 18, 2024
Image quality in CT thorax: effect of altering reconstruction algorithm and tube loadBharti Kataria, Mischa Woisetschläger, Jonas Nilsson Althén, et al.
Methods in Molecular Biology (Clifton, N.J.)|October 9, 2021
A Glycoproteomic Approach to Identify Novel ProteoglycansFredrik Noborn, Mahnaz Nikpour, Andrea Persson, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|May 4, 2012
Cost-effectiveness analysis of dronedarone versus other anti-arrhythmic drugs for the treatment of atrial fibrillation--results for Canada, Italy, Sweden and SwitzerlandJonas Nilsson, Örjan Åkerborg, Gaëlle Bégo-Le Bagousse, et al.
Plos One|May 13, 2020
Retrospective observational cohort study on innovation in oncology and progress in survival: How far have we gotten in the two decades of treating patients with advanced non-small cell lung cancer as a single population?Nahila Justo, Jonas Nilsson, Beata Korytowsky, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 8, 2022
Cost-effectiveness analysis of NEPA, a fixed-dose combination of netupitant and palonosetron, for the prevention of highly emetogenic chemotherapy-induced nausea and vomiting: an international perspectiveJonas Nilsson, Vittoria Piovesana, Marco Turini, et al.
Oncology Letters|April 30, 2017
Incidence trends in high-grade primary brain tumors in males and femalesJonas Nilsson, Georg Holgersson, Tobias Carlsson, et al.
Anticancer Research|July 5, 2020
Geographical Differences in Likelihood of Home Death Among Palliative Cancer Patients: A National Population-based Register StudyJonas Nilsson, Bertil Axelsson, Georg Holgersson, et al.
The American Journal of Hospice & Palliative Care|November 7, 2023
Prospective Study of Preferred Versus Actual Place of Death Among Swedish Palliative Cancer PatientsJonas Nilsson, Stefan Bergström, Hampus Hållberg, et al.
Glycobiology|May 17, 2021
Proteoglycan profiling of human, rat and mouse insulin-secreting cellsMahnaz Nikpour, Jonas Nilsson, Andrea Persson, et al.
Asia-Pacific Journal of Clinical Oncology|March 16, 2017
End-of-life care: Where do cancer patients want to die? A systematic reviewJonas Nilsson, Carl Blomberg, Georg Holgersson, et al.
Pageof 15

Showing results (41-50 of 146) with videos related to

Sort By:
Pageof 15
Radiation Protection Dosimetry|February 18, 2024
Image quality in CT thorax: effect of altering reconstruction algorithm and tube loadBharti Kataria, Mischa Woisetschläger, Jonas Nilsson Althén, et al.
Methods in Molecular Biology (Clifton, N.J.)|October 9, 2021
A Glycoproteomic Approach to Identify Novel ProteoglycansFredrik Noborn, Mahnaz Nikpour, Andrea Persson, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|May 4, 2012
Cost-effectiveness analysis of dronedarone versus other anti-arrhythmic drugs for the treatment of atrial fibrillation--results for Canada, Italy, Sweden and SwitzerlandJonas Nilsson, Örjan Åkerborg, Gaëlle Bégo-Le Bagousse, et al.
Plos One|May 13, 2020
Retrospective observational cohort study on innovation in oncology and progress in survival: How far have we gotten in the two decades of treating patients with advanced non-small cell lung cancer as a single population?Nahila Justo, Jonas Nilsson, Beata Korytowsky, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 8, 2022
Cost-effectiveness analysis of NEPA, a fixed-dose combination of netupitant and palonosetron, for the prevention of highly emetogenic chemotherapy-induced nausea and vomiting: an international perspectiveJonas Nilsson, Vittoria Piovesana, Marco Turini, et al.
Oncology Letters|April 30, 2017
Incidence trends in high-grade primary brain tumors in males and femalesJonas Nilsson, Georg Holgersson, Tobias Carlsson, et al.
Anticancer Research|July 5, 2020
Geographical Differences in Likelihood of Home Death Among Palliative Cancer Patients: A National Population-based Register StudyJonas Nilsson, Bertil Axelsson, Georg Holgersson, et al.
The American Journal of Hospice & Palliative Care|November 7, 2023
Prospective Study of Preferred Versus Actual Place of Death Among Swedish Palliative Cancer PatientsJonas Nilsson, Stefan Bergström, Hampus Hållberg, et al.
Glycobiology|May 17, 2021
Proteoglycan profiling of human, rat and mouse insulin-secreting cellsMahnaz Nikpour, Jonas Nilsson, Andrea Persson, et al.
Asia-Pacific Journal of Clinical Oncology|March 16, 2017
End-of-life care: Where do cancer patients want to die? A systematic reviewJonas Nilsson, Carl Blomberg, Georg Holgersson, et al.
Pageof 15